Start your intake Why Dual GLP-1 Therapy Is Not Recommended Both tirzepatide and semaglutide activate the GLP-1 receptor pathway
A list of properties was evaluated, including: molecular weight, number of rotatable bonds, hydrogen bond acceptors, hydrogen bond donors, molar refractivity, topological polar surface area, logarithm of solubility (ESOL), average of the logarithm of the partition coefficient (Consensus), inhibition of the main cytochrome P450 (CYP450) isoforms (1A2, 2C9, 2C19, 2D6, and 3A4), gastrointestinal absorption, bloodbrain barrier permeability and inhibitor or substrate for Pglycoprotein
If you have diabetes and kidney concerns, ask your doctor about these options
If you think youre deficient, talk with a healthcare professional to figure out the best option for you
You can also contact the Kidney Care UK helpline for emotional support and practical guidance
This medication was originally used to treat type 2 diabetes, but has also proven to be useful in weight-loss
